Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Dotinurad

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Crystalys Therapeutics Progresses Dotinurad Phase 3 Trials
    Crystalys Therapeutics Progresses Dotinurad Phase 3 Trials

    21 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/crystalys-therapeutics-advances-phase-3-trials-of-dotinurad-for-the-treatment-of-gout-with-dosing-of-first-patients-302589382.html

    PR NEWSWIRE
    21 Oct 2025
    Share Share
    Fortress, Urica Dose First Patients In Ph3 Dotinurad Gout Trial
    Fortress, Urica Dose First Patients In Ph3 Dotinurad Gout Trial

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3170212/28889/en/Fortress-Biotech-and-Subsidiary-Urica-Therapeutics-Announce-First-Patients-Dosed-in-Crystalys-Therapeutics-Global-Phase-3-Trials-of-Dotinurad-for-the-Treatment-of-Gout.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    Fortress Biotech And Urica Therapeutics Unveil Crystalys
    Fortress Biotech And Urica Therapeutics Unveil Crystalys

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159491/28889/en/Fortress-Biotech-and-Subsidiary-Urica-Therapeutics-Announce-Crystalys-Therapeutics-205-Million-Series-A-Financing.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    Revarazan Hcl For Acute Gastritis, Chronic Gastritis Gastric Mucosal Lesions
    Revarazan Hcl For Acute Gastritis, Chronic Gastritis Gastric Mucosal Lesions

    28 Mar 2024

    // PRESS RELEASE

    https://www.tantuchemicals.com/news/revarazan-hcl-for-acute-gastritis-chronic-gas-76202020.html

    PRESS RELEASE
    28 Mar 2024
    Share Share
    Urica Announces Topline Data from the Ph1 Trial Evaluating Dotinurad
    Urica Announces Topline Data from the Ph1 Trial Evaluating Dotinurad

    29 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/29/2696949/28889/en/Urica-Therapeutics-Announces-Topline-Data-from-the-Phase-1-Clinical-Trial-Evaluating-Dotinurad-in-Healthy-Volunteers-in-the-United-States.html

    GLOBENEWSWIRE
    29 Jun 2023
    Share Share
    Urica Therapeutics Expands Exclusive License Agreement with Fuji Yakuhin
    Urica Therapeutics Expands Exclusive License Agreement with Fuji Yakuhin

    14 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/12/14/2573643/28889/en/Urica-Therapeutics-Expands-Exclusive-License-Agreement-with-Fuji-Yakuhin-Co-Ltd-to-Develop-Dotinurad-in-Additional-Territories-Including-Turkey-and-the-Middle-East-and-North-Africa.html

    GLOBENEWSWIRE
    14 Dec 2022
    Share Share